Calciphylaxis Complicated By Candidemia In A Left Ventricular Assist Device Patient [Poster no. 623] (HFSA 2026) - Aug 17, 2026 - Abstract #Poster no. 623; Pres time: Oct 11, 2026; 12:45 PM - 01:15 PM; Location: ePoster Hub - Exhibit Hall 5-6 - PCC North; Monitor 17; "She was treated for cellulitis with ceftriaxone but continued to have persistent pain out of proportion to exam and development of wound eschar, prompting dermatology consultation for calciphylaxis...Warfarin was transitioned to unfractionated heparin and after risk-benefit discussions about anticoagulation for the HM3, apixaban was started...Despite HD catheter removal, drainage of the driveline fluid collection, and antifungal therapy with micafungin, liposomal amphotericin B, isavuconazole, and flucytosine, the patient remained fungemic, and her mental status declined...However, fungal infection in LVAD patients, particularly with a multi-drug resistant and invasive pathogen like C. auris, is associated with exceedingly high mortality risk. Device removal is often not feasible, limiting ability to attain source control."
Clinical • Calciphylaxis • Cardiomyopathy • Cardiovascular • Chronic Kidney Disease • CNS Disorders • Genetic Disorders • Hematological Disorders • Infectious Disease • Obesity • Rare Diseases • Renal Disease • Thrombosis
|
|
Gabriela M. Diaz1; Sailaja Bijani2; Rachel Tobin1; Kunal Bhatt1
|